Literature DB >> 20232242

Neurocognitive impairment and HIV risk factors: a reciprocal relationship.

Pria Anand1, Sandra A Springer, Michael M Copenhaver, Frederick L Altice.   

Abstract

Cognitive impairment among populations at risk for HIV poses a significant barrier to managing risk behaviors. The impact of HIV and several cofactors, including substance abuse and mental illness, on cognitive function is discussed in the context of HIV risk behaviors, medication adherence, and risk-reduction interventions. Literature suggests that cognitive impairment is intertwined in a close, reciprocal relationship with both risk behaviors and medication adherence. Not only do increased risk behaviors and suboptimal adherence exacerbate cognitive impairment, but cognitive impairment also reduces the effectiveness of interventions aimed at optimizing medication adherence and reducing risk. In order to be effective, risk-reduction interventions must therefore take into account the impact of cognitive impairment on learning and behavior.

Entities:  

Mesh:

Year:  2010        PMID: 20232242      PMCID: PMC2906682          DOI: 10.1007/s10461-010-9684-1

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  95 in total

1.  Effects of executive function impairment on change processes and substance use outcomes in 12-step treatment.

Authors:  J Morgenstern; M E Bates
Journal:  J Stud Alcohol       Date:  1999-11

Review 2.  Intervening effectively with drug abusers infected with HIV: taking into account the potential for cognitive impairment.

Authors:  Michael Copenhaver; S Kelly Avants; Lara A Warburton; Arthur Margolin
Journal:  J Psychoactive Drugs       Date:  2003 Apr-Jun

Review 3.  The role of executive cognitive functions in changing substance use: what we know and what we need to know.

Authors:  Arthur W Blume; G Alan Marlatt
Journal:  Ann Behav Med       Date:  2009-03-28

Review 4.  The relationship between neuropsychological functioning and HAART adherence in HIV-positive adults: a systematic review.

Authors:  Travis I Lovejoy; Julie A Suhr
Journal:  J Behav Med       Date:  2009-03-17

5.  Co-occurrence of treatment nonadherence and continued HIV transmission risk behaviors: implications for positive prevention interventions.

Authors:  Seth C Kalichman
Journal:  Psychosom Med       Date:  2008-06-02       Impact factor: 4.312

6.  Preliminary evidence of improved verbal working memory performance and normalization of task-related frontal lobe activation in schizophrenia following cognitive exercises.

Authors:  B E Wexler; M Anderson; R K Fulbright; J C Gore
Journal:  Am J Psychiatry       Date:  2000-10       Impact factor: 18.112

7.  Targeting HIV-related outcomes with intravenous drug users maintained on methadone: a randomized clinical trial of a harm reduction group therapy.

Authors:  S Kelly Avants; Arthur Margolin; Mary Helen Usubiaga; Cheryl Doebrick
Journal:  J Subst Abuse Treat       Date:  2004-03

8.  HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients.

Authors:  J Allen McCutchan; Julia W Wu; Kevin Robertson; Susan L Koletar; Ronald J Ellis; Susan Cohn; Michael Taylor; Steven Woods; Robert Heaton; Judith Currier; Paige L Williams
Journal:  AIDS       Date:  2007-05-31       Impact factor: 4.177

9.  Adherence to heroin dependence therapies and human immunodeficiency virus/acquired immunodeficiency syndrome infection rates among drug abusers.

Authors:  Silvana De Castro; Eduardo Sabaté
Journal:  Clin Infect Dis       Date:  2003-12-15       Impact factor: 9.079

Review 10.  Cognitive neuropsychology of HIV-associated neurocognitive disorders.

Authors:  Steven Paul Woods; David J Moore; Erica Weber; Igor Grant
Journal:  Neuropsychol Rev       Date:  2009-05-22       Impact factor: 7.444

View more
  69 in total

1.  Profiles of executive functioning: associations with substance dependence and risky sexual behavior.

Authors:  Sarit A Golub; Tyrel J Starks; William J Kowalczyk; Louisa I Thompson; Jeffrey T Parsons
Journal:  Psychol Addict Behav       Date:  2012-07-09

2.  Relationship of Medication Management Test-Revised (MMT-R) performance to neuropsychological functioning and antiretroviral adherence in adults with HIV.

Authors:  Doyle E Patton; Steven Paul Woods; Donald Franklin; Jordan E Cattie; Robert K Heaton; Ann C Collier; Christina Marra; David Clifford; Benjamin Gelman; Justin McArthur; Susan Morgello; David Simpson; J Allen McCutchan; Igor Grant
Journal:  AIDS Behav       Date:  2012-11

3.  Modeling a Theory-Based Approach to Examine the Influence of Neurocognitive Impairment on HIV Risk Reduction Behaviors Among Drug Users in Treatment.

Authors:  Tania B Huedo-Medina; Roman Shrestha; Michael Copenhaver
Journal:  AIDS Behav       Date:  2016-08

4.  The Acceptability and Potential Utility of Cognitive Training to Improve Working Memory in Persons Living With HIV: A Preliminary Randomized Trial.

Authors:  Sheri L Towe; Puja Patel; Christina S Meade
Journal:  J Assoc Nurses AIDS Care       Date:  2017-03-30       Impact factor: 1.354

Review 5.  Dilemma of concepts and strategies for the prevention of spread of HIV in relation to human behavior, law and human rights.

Authors:  Reinhard H Dennin; Michael Lafrenz; Arndt Sinn; Lan-juan Li
Journal:  J Zhejiang Univ Sci B       Date:  2011-07       Impact factor: 3.066

Review 6.  14-3-3s are potential biomarkers for HIV-related neurodegeneration.

Authors:  Diana Morales; Efthimios C M Skoulakis; Summer F Acevedo
Journal:  J Neurovirol       Date:  2012-07-19       Impact factor: 2.643

7.  The development of inhibitory control in adolescence and prospective relations with delinquency.

Authors:  Whitney D Fosco; Larry W Hawk; Craig R Colder; Samuel N Meisel; Liliana J Lengua
Journal:  J Adolesc       Date:  2019-08-20

8.  Correlates of willingness to initiate pre-exposure prophylaxis and anticipation of practicing safer drug- and sex-related behaviors among high-risk drug users on methadone treatment.

Authors:  Roman Shrestha; Pramila Karki; Frederick L Altice; Tania B Huedo-Medina; Jaimie P Meyer; Lynn Madden; Michael Copenhaver
Journal:  Drug Alcohol Depend       Date:  2017-02-02       Impact factor: 4.492

Review 9.  Alcohol Use and Human Immunodeficiency Virus (HIV) Infection: Current Knowledge, Implications, and Future Directions.

Authors:  Emily C Williams; Judith A Hahn; Richard Saitz; Kendall Bryant; Marlene C Lira; Jeffrey H Samet
Journal:  Alcohol Clin Exp Res       Date:  2016-09-22       Impact factor: 3.455

10.  A non-inferiority trial of an evidence-based secondary HIV prevention behavioral intervention compared to an adapted, abbreviated version: Rationale and intervention description.

Authors:  Roman Shrestha; Archana Krishnan; Frederick L Altice; Michael Copenhaver
Journal:  Contemp Clin Trials       Date:  2015-08-05       Impact factor: 2.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.